Funded Biotechnology Startups in Switzerland
Across the 50 most recent disclosed biotechnology rounds in Switzerland, MoonLake Immunotherapeutics’ $200M raise on 2026-06-23 stands out: it is the only…
Across the 50 most recent disclosed biotechnology rounds in Switzerland, MoonLake Immunotherapeutics’ $200M raise on 2026-06-23 stands out: it is the only disclosed round above $100M, while the next-largest disclosed amounts cluster much lower (for example Pharvaris at $132M on 2026-05-08 and Windward Bio at $165M on 2026-05-04). At the other extreme, the smallest disclosed amount is DropGen’s $30K pre-seed on 2025-07-23, with several early-stage rounds also concentrated in the low six-figure range (e.g., Cria Technologies $120K on 2026-06-21 and Emovo Care $110K on 2025-11-06).
Temporal and location patterns are also noticeable. Rounds are dense in late June 2026 (compliances through 2026-06-24, including MoonLake Immunotherapeutics on 2026-06-23 and Isospec Analytics on 2026-06-23), and multiple entries repeat across Zurich-area addresses (e.g., MindMaze in Lausanne is frequent too, but Zurich/Zürich-based companies appear repeatedly such as Neurosoft Bioelectronics on 2026-05-20 for Zurich and ImmunOs Therapeutics in Schlieren on 2024-09-17). Stage labeling is frequently incomplete: 27 of 50 rows are “Series Unknown,” and 4 are marked “undisclosed” for amount, which complicates any size-at-stage comparisons. Disclosed rounds span 2024-09-17 (ImmunOs Therapeutics) through 2026-06-24 (compliag AG).
Most recent rounds
50 of 13383 more funded startups
This page shows the 50 most recent rounds (back to Sep 2024). The full 133-company history for this listing is available on a paid plan.
Unlock all 133 companies in this listing — full funding history, investors, and founders.
Related listings
Frequently asked
What’s the largest disclosed biotech round in this Switzerland list, and how far above the rest is it?
MoonLake Immunotherapeutics’ $200M round on 2026-06-23 is the only disclosed amount above $100M. The next-largest disclosed examples are Windward Bio’s $165M (2026-05-04) and Pharvaris’ $132M (2026-05-08), both well below the $200M outlier.
Are there size outliers on the low end that meaningfully undercut the distribution?
DropGen’s $30K pre-seed on 2025-07-23 is the smallest disclosed amount in the list. Several early-stage rounds are also relatively small (e.g., Cria Technologies $120K on 2026-06-21 and Emovo Care $110K on 2025-11-06), but none match the $30K floor.
Do the most recent rounds cluster within a narrow time window?
Yes. Late June 2026 is especially dense, with multiple entries dated 2026-06-23 (MoonLake Immunotherapeutics $200M; Isospec Analytics $490K) and additional rounds immediately around them (e.g., compliag AG $1M on 2026-06-24 and Immitra Bio $190K on 2026-06-15).
Which stage labels dominate, and how does that affect comparisons of fundraising size by stage?
“Series Unknown” appears in 27 of 50 rows, making stage-vs-size analysis difficult on a like-for-like basis. Even when amounts are disclosed, many of the largest rounds sit under “Series Unknown” (e.g., MoonLake Immunotherapeutics $200M on 2026-06-23; Pharvaris $132M on 2026-05-08), so the biggest datapoints are not confined to a single labeled stage.
Are there repeat geography signals within Switzerland (beyond the country-level label)?
Zurich-area addresses recur across multiple entries, including Neurosoft Bioelectronics in Geneva (2026-05-20, $8M) and multiple companies tied to Zürich/Zürich-based locales and nearby municipalities such as Schlieren (Immitra Bio on 2026-06-15; ImmunOs Therapeutics on 2024-09-17 for $11M). The same pattern is also visible in other cantons like Vaud (e.g., Isospec Analytics in Lausanne on 2026-06-23; SamanTree Medical in Lausanne on 2026-01-27 for $24M).
Which entries are best treated as “data gaps” for analysis because the amount wasn’t disclosed?
Four rows are marked “undisclosed” for amount: ClearideBio Therapeutics (Pre-Seed, 2026-06-11), SentiaNova (Seed, 2026-04-23), Arktis Radiation Detectors (Series Unknown, 2025-04-23), and ELDICO Scientific (Series Unknown, 2024-10-08), plus GliaPharm (Series Unknown, 2024-09-17). These can’t be used for largest/smallest comparisons, but their dates help identify where fundraising activity occurred despite missing disclosed totals.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.